Indegene

Last updated

Indegene Limited
FormerlyIndegene Lifesystems Private Limited (1998–2016)
Indegene Private Limited (2016–2022)
Company type Public
Industry Pharmaceutical consultancy [1]
Founded1998;27 years ago (1998)
FoundersRajesh Nair
Manish Gupta
Sanjay Parikh
Anand Kiran
Gaurav Kapoor
Headquarters
Bangalore
,
India
Area served
Worldwide
Key people
Manish Gupta (CEO) [2]
RevenueIncrease2.svg₹2,589 crore (US$310 million) (FY24) [3]
Increase2.svg₹584 crore (US$69 million) (FY24) [3]
Increase2.svg₹336 crore (US$40 million) (FY24) [3]
Owners
Number of employees
5,081 (March 2024) [3]
Website www.indegene.com

Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. [5] [6] [7] Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. [8] [9]

Contents

History

Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran. [10] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States. [11] In 2008, Medsn officially became Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States. [7] [12]

In 2009, Indegene signed a master service agreement with six pharmaceutical companies. [6] [13] The following year, Indegene acquired Canada-based Aptilon, a multichannel marketing firm, for $4 million. [14] The company subsequently acquired Atlanta-based Total Therapeutic Management in 2014. [15]

In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million. [16]

In February 2021, the Carlyle Group and Brighton Park Capital invested $200 million in Indegene. [17] In August 2021, Indegene acquired Medical Marketing Economics (MME), an American market access and pricing strategy company, for $10 million. [18]

Indegene went public in May 2024 with an initial public offering, raising ₹1,842 crore (US$220 million). It listed on the BSE and the NSE. [19] [20]

Operations

Indegene has offices in India, the United States, the European Union, and Asia-Pacific. [21] [12]

In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry. [22]

References

  1. ↑ "Indegene ends 26% higher on listing day". 13 May 2024.
  2. ↑ "Indegene on the prowl for global acquisitions". The Hindu Businessline. 12 August 2020. Retrieved 8 January 2023.
  3. 1 2 3 4 "Fact Sheet – Q4 FY2024" (PDF). Indegene. Retrieved 30 May 2024.
  4. ↑ "Carlyle Group sells 4.3% in Indegene for ₹636 cr". The Economic Times. 3 December 2024. Retrieved 4 December 2024.
  5. ↑ Das, Avik (2 September 2015). "Flipkart, Practo CEOs get top rating from staff". The Economic Times . Archived from the original on 8 September 2015. Retrieved 2 October 2015.
  6. 1 2 Singh, Seema (7 May 2009). "Cutting pharma costs by intelligent marketing". Mint . Retrieved 2 October 2015.
  7. 1 2 Unnikrishnan, CH (8 November 2006). "Indegene buys US firm". Business Standard . Retrieved 2 October 2015.
  8. ↑ Murayama, Keiichi (19 February 2015). "India's tech muscle has the world's attention". The Nikkei . Retrieved 2 October 2015.
  9. ↑ "Indegene files papers with Sebi; eyes ₹3,200 crore via IPO". mint. 15 December 2022. Retrieved 8 January 2023.
  10. ↑ Amirapu, Deepika (9 March 2012). "Indegene eyes US call centre buy for $10–15 million". The Economic Times . Archived from the original on 19 November 2015. Retrieved 2 October 2015.
  11. ↑ D'Silva, Jeetha (17 September 2005). "Indegene acquires US medical education co". The Economic Times . Archived from the original on 16 October 2015. Retrieved 2 October 2015.
  12. 1 2 "Indegene acquires MedCases, LLC". NFV Zone. 30 November 2006. Retrieved 2 October 2015.
  13. ↑ "Indegene highlights benefits of patient adherence programs for pharma cos". PharmaBiz. 3 June 2011. Archived from the original on 19 November 2015. Retrieved 2 October 2015.
  14. ↑ Mukherjee, Rupali (7 November 2012). "Indegene to acquire Canada-based company for $4 million". Times of India . Retrieved 2 October 2015.
  15. ↑ Craig, Tara (9 January 2014). "Indegene acquires Total Therapeutic Management". PMLive.com. Retrieved 2 October 2015.
  16. ↑ Balakrishnan, Reghu (3 September 2019). "Healthcare tech firm Indegene acquires DT Associates". The Economic Times. Retrieved 28 April 2024.
  17. ↑ Madhurima, Nandy (3 February 2021). "Indegene to raise $200 mn from Carlyle, Brighton Park". LiveMint . Retrieved 20 August 2021.
  18. ↑ Baruah, Ayushman (30 August 2021). "Indegene acquires US-based Medical Marketing Economics for $10 mn". Mint. Retrieved 28 April 2024.
  19. ↑ Narayanan, KS Badri (6 May 2024). "Indegene IPO opens today in ₹430-452 price band". BusinessLine. Retrieved 6 May 2024.
  20. ↑ "PE firms Carlyle, Nadathur Fareast, Brighton Park Capital-backed Indegene IPO to open on May 6". Moneycontrol. Retrieved 28 April 2024.
  21. ↑ Vijay, Nandita (7 November 2012). "Indegene plans next phase of growth through acquisition in US, EU markets". PharmaBiz. Archived from the original on 19 November 2015. Retrieved 2 October 2015.
  22. ↑ "Best companies to work for 2012: Companies that came up trumps across various sectors". The Economic Times . 16 July 2012. Archived from the original on 11 April 2013. Retrieved 2 October 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.